Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Federico Bardazzi and Ambra Di Altobrando.
Federico Bardazzi
Connection Strength
2.886
Ambra Di Altobrando
  1. Rituximab: a safe therapeutic option during the COVID-19 pandemic? J Dermatolog Treat. 2020 Jul 29; 1.
    View in: PubMed
    Score: 0.895
  2. Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? J Eur Acad Dermatol Venereol. 2020 Jul; 34(7):e295-e297.
    View in: PubMed
    Score: 0.890
  3. Biologic therapy for psoriasis during the covid-19 outbreak is not a choice. J Dermatolog Treat. 2020 06; 31(4):320-321.
    View in: PubMed
    Score: 0.876
  4. How infodemic during the COVID-19 outbreak influenced common clinical practice in an Outpatient Service of Severe Psoriasis. Dermatol Ther. 2020 11; 33(6):e14065.
    View in: PubMed
    Score: 0.225
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.